Jamieson Wellness (TSE:JWEL – Get Free Report) was downgraded by research analysts at TD from a “buy” rating to a “hold” rating in a research note issued to investors on Monday,BayStreet.CA reports. They currently have a C$49.00 price target on the stock, up from their previous price target of C$48.00. TD’s price target points to a potential upside of 7.55% from the stock’s current price.
Other research analysts have also issued reports about the stock. Stifel Nicolaus lowered shares of Jamieson Wellness from a “buy” rating to a “hold” rating and upped their target price for the stock from C$45.00 to C$45.75 in a research report on Friday. Canadian Imperial Bank of Commerce lowered Jamieson Wellness from an “outperformer” rating to a “tender” rating and boosted their price target for the stock from C$44.00 to C$45.75 in a research note on Friday. Two equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, Jamieson Wellness presently has an average rating of “Hold” and an average price target of C$46.43.
Get Our Latest Research Report on JWEL
Jamieson Wellness Price Performance
Jamieson Wellness (TSE:JWEL – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported C$0.46 earnings per share (EPS) for the quarter. The firm had revenue of C$233.84 million during the quarter. Jamieson Wellness had a net margin of 8.92% and a return on equity of 15.93%. As a group, analysts anticipate that Jamieson Wellness will post 2.1438892 EPS for the current year.
Jamieson Wellness Company Profile
Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.
Read More
- Five stocks we like better than Jamieson Wellness
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
